Blueblood Ventures Ltd
Blueblood Ventures is engaged in the business of equity investment and trading in equity, derivatives, currencies,futures and options and commodities ,Venture capital funding and other financial products.
- Market Cap ₹ 3.32 Cr.
- Current Price ₹ 11.1
- High / Low ₹ /
- Stock P/E 166
- Book Value ₹ 9.87
- Dividend Yield 0.00 %
- ROCE 0.01 %
- ROE 0.71 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 1.12 times its book value
Cons
- Company has a low return on equity of 0.71% over last 3 years.
- Contingent liabilities of Rs.9.35 Cr.
- Company might be capitalizing the interest cost
- Company has high debtors of 4,766 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Finance Industry: Finance & Investments
Half Yearly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0.74 | 1.60 | 3.11 | 0.72 | 2.73 | 59.82 | 0.73 | 0.53 | -0.32 | 0.68 | 0.20 | 0.51 | |
0.56 | 1.25 | 0.30 | -10.13 | -1.70 | 55.30 | 0.90 | 3.41 | 0.34 | 0.66 | 0.15 | 0.50 | |
Operating Profit | 0.18 | 0.35 | 2.81 | 10.85 | 4.43 | 4.52 | -0.17 | -2.88 | -0.66 | 0.02 | 0.05 | 0.01 |
OPM % | 24.32% | 21.88% | 90.35% | 1,506.94% | 162.27% | 7.56% | -23.29% | -543.40% | -143.48% | 2.94% | 25.00% | 1.96% |
0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.02 | 0.07 | 0.00 | 0.00 | 0.00 | 0.03 | |
Interest | 0.10 | 0.27 | 2.68 | 10.63 | 4.11 | 3.30 | 0.04 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation | 0.01 | 0.03 | 0.03 | 0.04 | 0.03 | 0.81 | 0.02 | 0.01 | 0.01 | 0.00 | 0.04 | 0.03 |
Profit before tax | 0.07 | 0.05 | 0.12 | 0.18 | 0.29 | 0.41 | -0.21 | -2.84 | -0.67 | 0.02 | 0.01 | 0.01 |
Tax % | 28.57% | 40.00% | 25.00% | 27.78% | 31.03% | 24.39% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -200.00% |
0.05 | 0.04 | 0.09 | 0.12 | 0.20 | 0.30 | -0.21 | -2.85 | -0.66 | 0.02 | 0.02 | 0.02 | |
EPS in Rs | 5.00 | 2.00 | 1.80 | 0.40 | 0.67 | 1.00 | -0.70 | -9.50 | -2.20 | 0.07 | 0.07 | 0.07 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | -11% |
5 Years: | -7% |
3 Years: | % |
TTM: | 155% |
Compounded Profit Growth | |
---|---|
10 Years: | -7% |
5 Years: | 16% |
3 Years: | 27% |
TTM: | 0% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 3% |
3 Years: | % |
1 Year: | 0% |
Return on Equity | |
---|---|
10 Years: | -4% |
5 Years: | -21% |
3 Years: | 1% |
Last Year: | 1% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 0.13 | 0.22 | 0.53 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 |
Reserves | 3.59 | 6.25 | 7.49 | 12.10 | 12.26 | 12.56 | 3.30 | 0.46 | -0.21 | -0.19 | -0.17 | -0.04 |
4.94 | 7.25 | 37.15 | 100.20 | 141.87 | 137.31 | 94.25 | 94.04 | 94.00 | 94.00 | 94.00 | 94.12 | |
1.90 | 2.92 | 17.61 | 22.28 | 1.05 | 1.87 | 1.47 | 1.67 | 1.14 | 0.29 | 0.36 | 0.31 | |
Total Liabilities | 10.56 | 16.64 | 62.78 | 137.58 | 158.18 | 154.74 | 102.02 | 99.17 | 97.93 | 97.10 | 97.19 | 97.39 |
0.02 | 0.08 | 0.12 | 0.08 | 0.07 | 0.05 | 0.03 | 0.02 | 0.01 | 0.02 | 0.08 | 0.06 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.49 | 0.36 | 0.00 | 0.13 | 5.79 | 5.83 | 81.63 | 72.77 | 70.27 | 70.57 | 65.27 | 41.79 |
10.05 | 16.20 | 62.66 | 137.37 | 152.32 | 148.86 | 20.36 | 26.38 | 27.65 | 26.51 | 31.84 | 55.54 | |
Total Assets | 10.56 | 16.64 | 62.78 | 137.58 | 158.18 | 154.74 | 102.02 | 99.17 | 97.93 | 97.10 | 97.19 | 97.39 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0.70 | -1.18 | -33.70 | -59.78 | -5.00 | 130.27 | -11.44 | -5.91 | -0.89 | -1.36 | -0.68 | -7.09 | |
0.88 | 0.50 | 0.59 | 0.01 | -5.53 | 0.08 | 49.21 | 6.16 | 0.85 | 1.36 | 0.71 | 7.09 | |
-1.04 | 4.76 | 28.68 | 59.38 | 10.44 | -130.39 | -37.76 | -0.21 | 0.00 | 0.00 | 0.00 | 0.00 | |
Net Cash Flow | 0.54 | 4.08 | -4.43 | -0.39 | -0.08 | -0.04 | 0.01 | 0.04 | -0.04 | 0.00 | 0.03 | 0.00 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 1,282.43 | 584.00 | 1.17 | 0.00 | 0.00 | 0.00 | 0.00 | 1,225.85 | -2,041.72 | 960.81 | 12,154.50 | |
Inventory Days | 460.22 | 379.31 | 3.84 | 498.37 | 52.55 | 660.48 | 129.78 | |||||
Days Payable | 1,460.00 | 1,012.70 | 2.69 | 126.35 | 86.63 | 121.67 | 113.56 | |||||
Cash Conversion Cycle | 282.65 | -49.38 | 1.17 | 0.00 | 0.00 | 1.14 | 372.02 | 1,191.76 | -1,502.91 | 977.03 | 12,154.50 | |
Working Capital Days | 3,590.81 | 1,902.56 | 5,223.84 | 58,268.19 | 20,216.72 | 19.22 | 30.00 | 833.30 | 2,064.53 | 901.76 | 12,099.75 | |
ROCE % | 1.87% | 2.86% | 9.51% | 13.47% | 3.23% | 2.39% | -0.13% | -2.85% | -0.69% | 0.02% | 0.01% |
Documents
Announcements
- Pursuant To Regulation 30 Of The Securities Exchange Board Of India (LODR) Requirements, 2015 Approves The Standalone Audited Financial Results For The Financial Year Ended 2023-2024 Along With Auditor Report. 27 May
-
Announcement under Regulation 30 (LODR)-Change in Directorate
27 May - Securities Exchange Board of India ( listing obligations and Disclosures Requirements) Regulations, 2015, Mr. Pushpendra Surana ceases to be a Director of the Company with …
- Board Meeting Outcome for The Board Has Decided To Approve The Standalone Annual Audited Financials Results For The Financial Year Ended 2023-24 Along With Auditor Report Thereon. 27 May
- Closure of Trading Window 18 May
- Board Meeting Intimation for To Consider And Approve Audited Standalone Financials Results And Resignation Of Mr. Pushpendra Surana 18 May